国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2014年
19期
3001-3003
,共3页
曾宪杰%孙光裕%曾培灿%林玉芳
曾憲傑%孫光裕%曾培燦%林玉芳
증헌걸%손광유%증배찬%림옥방
单唾液酸四己糖神经节苷脂钠%Binswanger病%MMSE%ADL
單唾液痠四己糖神經節苷脂鈉%Binswanger病%MMSE%ADL
단타액산사기당신경절감지납%Binswanger병%MMSE%ADL
Monosialotetrahexosylganglioside sodium%Binswanger's disease%Mini-mental state examination%Activities of daily living
目的 观察单唾液酸四己糖神经节苷脂钠对Binswanger病患者认知力及日常生活能力的影响.方法 将56例Binswanger病患者随机分为治疗组和对照组各28例,两组患者均予常规治疗,治疗组患者在此基础上给予单唾液酸四己糖神经节苷脂钠静滴,对照组患者给予胞二磷胆碱静滴,14天后采用MMSE量表和ADL量表评价两组患者的认知力及日常生活能力变化情况.结果 治疗组患者MMSE量表改善总有效率为75%、ADL量表改善总有效率为67.86%,对照组患者MMSE量表改善总有效率为35.71%、ADL量表改善总有效率为32.14%.结论 单唾液酸四己糖神经节苷脂钠治疗Binswanger病能够较好改善患者认知力及日常生活能力.
目的 觀察單唾液痠四己糖神經節苷脂鈉對Binswanger病患者認知力及日常生活能力的影響.方法 將56例Binswanger病患者隨機分為治療組和對照組各28例,兩組患者均予常規治療,治療組患者在此基礎上給予單唾液痠四己糖神經節苷脂鈉靜滴,對照組患者給予胞二燐膽堿靜滴,14天後採用MMSE量錶和ADL量錶評價兩組患者的認知力及日常生活能力變化情況.結果 治療組患者MMSE量錶改善總有效率為75%、ADL量錶改善總有效率為67.86%,對照組患者MMSE量錶改善總有效率為35.71%、ADL量錶改善總有效率為32.14%.結論 單唾液痠四己糖神經節苷脂鈉治療Binswanger病能夠較好改善患者認知力及日常生活能力.
목적 관찰단타액산사기당신경절감지납대Binswanger병환자인지력급일상생활능력적영향.방법 장56례Binswanger병환자수궤분위치료조화대조조각28례,량조환자균여상규치료,치료조환자재차기출상급여단타액산사기당신경절감지납정적,대조조환자급여포이린담감정적,14천후채용MMSE량표화ADL량표평개량조환자적인지력급일상생활능력변화정황.결과 치료조환자MMSE량표개선총유효솔위75%、ADL량표개선총유효솔위67.86%,대조조환자MMSE량표개선총유효솔위35.71%、ADL량표개선총유효솔위32.14%.결론 단타액산사기당신경절감지납치료Binswanger병능구교호개선환자인지력급일상생활능력.
Objective To observe impact of monosialotetrahexosylganglioside (GM1) sodium on cognition and daily living ability of patients with Binswanger.Methods 56 cases of Binswanger were randomly divided into treatment group and control group with 28 cases in each group,and patients were given traditional treatment.Treatment group was added with GM1 sodium infusion,while control group was treated with citicoline infusion.After 14 days of treatment,changes in cognition and daily living ability of two groups were evaluated by Mini-mental State Examination (MMSE) scale and Activities of Daily Living (ADL) scale.Results For treatment group,the total effective rate of MMSE scale improvement was 75%,and that of ADL scale improvement was 67.86%.But for control group,the total effective rate of MMSE scale improvement was 35.71%,and that of ADL scale improvement was 32.14%.Therefore,the treatment group was significantly superior to the control group,with statistically significant differences (P < 0.05).Conclusion GM1 sodium treatment can better improve cognition and daily living ability of patients with Binswanger.